Kestra Medical Technologies (KMTS) Gross Profit (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Gross Profit data on file, last reported at $15.7 million in Q2 2026.

• On a quarterly basis, Gross Profit rose 105.45% year-over-year to $15.7 million in Q2 2026; TTM through Apr 2026 was $48.9 million, a 101.83% increase from a year earlier, with the FY2026 full-year figure at $48.9 million, up 101.83% from the prior year.
• Gross Profit for Q2 2026 stood at $15.7 million, up from $12.9 million in the prior quarter.
• Over the last five years, Gross Profit for KMTS reached as high as $15.7 million in Q2 2026 and fell as low as $880000.0 in Q1 2024.
• Historically, Gross Profit has averaged $7.5 million across 3 years, with a median of $7.1 million in 2025.
• On a YoY basis, Gross Profit climbed as much as 643.98% in 2025 and fell as far as 95.95% in 2025.
• Year by year, Gross Profit stood at $5.8 million in 2024, then surged by 95.95% to $11.4 million in 2025, then surged by 37.27% to $15.7 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $15.7 million in Q2 2026, $12.9 million in Q1 2026, and $11.4 million in Q4 2025.